Ö. F. ÖLMEZ Et Al. , "Anti-Ri-associated paraneoplastic neurological syndrome: Initial symptom of breast cancer with HER2 overexpression and treatment by dual HER2 blockade," Journal of Oncology Pharmacy Practice , vol.25, no.6, pp.1526-1530, 2019
ÖLMEZ, Ö. F. Et Al. 2019. Anti-Ri-associated paraneoplastic neurological syndrome: Initial symptom of breast cancer with HER2 overexpression and treatment by dual HER2 blockade. Journal of Oncology Pharmacy Practice , vol.25, no.6 , 1526-1530.
ÖLMEZ, Ö. F., Kinikoglu, O., Yilmaz, N. H., BİLİCİ, A., ÇUBUKÇU, E., ŞEKER, M., ... ÇAKIR, T.(2019). Anti-Ri-associated paraneoplastic neurological syndrome: Initial symptom of breast cancer with HER2 overexpression and treatment by dual HER2 blockade. Journal of Oncology Pharmacy Practice , vol.25, no.6, 1526-1530.
ÖLMEZ, Ömer Et Al. "Anti-Ri-associated paraneoplastic neurological syndrome: Initial symptom of breast cancer with HER2 overexpression and treatment by dual HER2 blockade," Journal of Oncology Pharmacy Practice , vol.25, no.6, 1526-1530, 2019
ÖLMEZ, Ömer F. Et Al. "Anti-Ri-associated paraneoplastic neurological syndrome: Initial symptom of breast cancer with HER2 overexpression and treatment by dual HER2 blockade." Journal of Oncology Pharmacy Practice , vol.25, no.6, pp.1526-1530, 2019
ÖLMEZ, Ö. F. Et Al. (2019) . "Anti-Ri-associated paraneoplastic neurological syndrome: Initial symptom of breast cancer with HER2 overexpression and treatment by dual HER2 blockade." Journal of Oncology Pharmacy Practice , vol.25, no.6, pp.1526-1530.
@article{article, author={Ömer Fatih ÖLMEZ Et Al. }, title={Anti-Ri-associated paraneoplastic neurological syndrome: Initial symptom of breast cancer with HER2 overexpression and treatment by dual HER2 blockade}, journal={Journal of Oncology Pharmacy Practice}, year=2019, pages={1526-1530} }